Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
207 participants
OBSERVATIONAL
2022-06-17
2024-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Telerehabilitation in Individuals With Temporomandibular Joint Dysfunction and Myofascial Pain
NCT06526845
Tele-Rehabilitation in Patients With Temporomandibular Dysfunction
NCT05006963
Endogenous Pain Inhibition Deficiency in Chronic TMD Pain
NCT06617494
Assessing the Effectiveness of Two Treatment Strategies for Tension-type Headache
NCT01347684
Efficacy of Physiotherapy in Patients With Temporomandibular Disorders.
NCT03555201
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Telerehabilitation only
Participants choose to have all of their physical therapy provided virtually throughout the length of the study
Telerehabilitation
The TR PT evaluation and follow-up visits will be performed via Zoom software
In-person only
Participants choose to have all of their physical therapy provided in-person throughout the length of the study
No interventions assigned to this group
Hybrid 1
The TR PT evaluation and follow-up visits in the initial 6 weeks will be performed via Zoom software and subsequent follow-up visits will switch to in person after 6 weeks
Telerehabilitation
The TR PT evaluation and follow-up visits will be performed via Zoom software
Hybrid 2
The PT evaluation and follow-up visits in the initial 6 weeks will be performed in person and will switch to TR via Zoom software after 6 weeks
Telerehabilitation
The TR PT evaluation and follow-up visits will be performed via Zoom software
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Telerehabilitation
The TR PT evaluation and follow-up visits will be performed via Zoom software
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Referred to PT with ≥1 TMD subtype diagnosis
* PI has no previous knowledge of the participant's diagnosis
* Email access
* Possession of any device that can be positioned for hands-free TR visits (TR group only)
* Willingness and ability to comply with all study requirements and PT program
* Able to provide informed consent
Exclusion Criteria
* Permanent residence outside of the state of Minnesota (TR group only)
* Women in the last trimester of pregnancy
* Referred for post-surgical rehabilitation
* Severe chronic pain as identified by level 4 classification on the GCPS
* Current diagnosis or existence of the following conditions that can limit response to PT and participation in study activities:
1. Neuropathic pain
2. Fibromyalgia and/or generalized widespread pain on both sides of the body in ≥3 areas above and below the waist
3. Rheumatoid arthritis or juvenile idiopathic arthritis
4. Dystonia or other movement disorder
5. Fractures and/or recent jaw or facial trauma
6. Malignancies
7. Current substance abuse
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Minnesota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emily Kahnert
Role: PRINCIPAL_INVESTIGATOR
University of Minnesota
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Minnesota
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DENT-2022-30141
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.